HCAlaboratories

What HCAlaboratories does

HCA UK Laboratories is the pathology services division of HCA International Limited, a private UK subsidiary of NYSE-listed HCA Healthcare. The business operates three ISO 15189:2022-accredited laboratories in London — Shropshire House (WC1), London Bridge Hospital (SE1), and the Leaders in Oncology Care laboratory on Harley Street (W1) — and has accumulated over 35 years of pathology experience (UKAS: 9059). Service delivery spans four laboratory disciplines: Blood Sciences (biochemistry, haematology, blood transfusion), Infection and Immunity (immunology including allergy, serology, virology, microbiology), Cellular Pathology (cytology, histopathology), and Genomics, including the Sarah Cannon Molecular Diagnostics partnership for personalised oncology testing.

The laboratory is primarily a captive, embedded service for HCA UK's private hospital network — which spans The Harley Street Clinic, London Bridge Hospital, The Wellington, The Portland, The Lister, The Harborne Hospital (Birmingham), The Christie Private Care, The Princess Grace, The Wilmslow, and University College Hospital Private Care — supporting self-pay, insured, and international patients (the latter routed through the HCA UK Concierge Centre). A secondary external ordering channel accepts specimens from independent IVF clinics, primary care providers, and healthcare screening organisations via phone, email, or direct clinical contact. Recent product launches include CaRi-heart cardiovascular risk-prediction technology (August 2025), Medtronic's Affera Mapping and Ablation System (June 2026 in source), and bispecific antibody therapy for lung cancer (2025).

The business model is professional services: quote-based pricing with no publicly disclosed fees, multi-year contract structures, billing through HCA UK infrastructure, and patient interactions managed through the My HCA portal. GTM motion is enterprise field sales within the HCA UK network combined with direct-enquiry external-provider intake. The laboratory is a single legal entity (HCA International Limited) within a much larger healthcare group, with no standalone capital structure, funding rounds, or disclosed financial reporting.

Name

HCAlaboratories

Legal name

HCA International Limited

Website

https://hcalaboratories.co.uk

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

HCA UK Laboratories is the in-house pathology division of HCA International Limited, operating three ISO 15189:2022-accredited laboratories across London that provide diagnostic testing in Blood Sciences, Infection and Immunity, Cellular Pathology, and Genomics/Molecular Diagnostics to HCA UK hospitals and external IVF, primary-care, and screening providers.

Ownership category

akta.pro rank

Product category

Pathology Laboratory Services

NAICS

Medical Laboratories (621511), Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industries

Hematology & Coagulation Laboratories (HLAFAMAC), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Pathology laboratory services
• Diagnostic testing services
• Molecular diagnostics
• Clinical laboratory testing
• Medical diagnostic laboratory

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pathology Testing Services: Laboratory analysis and diagnostic testing services provided to HCA UK hospitals and clinics, as well as independent healthcare providers including IVF clinics, primary care providers, and healthcare screening services. Services include routine analyses and bespoke testing with demanding turnaround times.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

HCA UK Laboratories is an ISO 15189:2022 accredited pathology laboratory operating across multiple London sites (Shropshire House, London Bridge, and Leaders in Oncology Care Laboratory), providing diagnostic testing services across four core disciplines: blood sciences, infection and immunity, cellular pathology, and genomics/Sarah Cannon molecular diagnostics. Services are delivered both to HCA UK hospitals and to external healthcare providers including IVF clinics, primary care providers, and urgent care centers, with additional cardiovascular risk assessment via the CaRi-heart test.

Product overview

HCA Healthcare UK Laboratories is a unified pathology services provider with over 35 years of experience, offering ISO 15189:2022 accredited testing across multiple disciplines. The service portfolio consists of four main laboratory disciplines: Blood Sciences (biochemistry, haematology, blood transfusion), Infection and Immunity (immunology/allergy, serology, virology, microbiology), Cellular Pathology (cytology, histopathology), and Genomics including Sarah Cannon Molecular Diagnostics. Services are delivered through three physical laboratory locations in London (Shropshire House, London Bridge, and Leaders in Oncology Care), serving HCA UK hospitals, clinics, and external independent providers including IVF clinics, primary care providers, and healthcare screenings.

Differentiator

Problem solved

Functional benefit

Brands

• Sarah Cannon Molecular Diagnostics: Molecular diagnostics service within HCA UK Laboratories providing genomic testing and diagnostics.

Products and services

• Blood Sciences

Quantifiable outcome

• ISO 15189:2022 (UKAS: 9059) accreditation demonstrates compliance with international quality standards for medical laboratories
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Sarah CannoncoreStrategic or Co-development PartnerSarah Cannon Molecular Diagnostics partnership providing advanced genomics and molecular diagnostic testing for personalized cancer treatment and care. This strategic collaboration enables HCA UK Laboratories to offer cutting-edge molecular diagnostics supporting oncology care across the HCA UK network.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Synlab UK: Synlab operates one of Europe's largest medical laboratory networks with significant UK presence, providing clinical diagnostics, pathology, and reference laboratory services to hospitals and healthcare providers. Directly competes with HCA UK Labs for private hospital and external referrer contracts.
• Unilabs UK: Unilabs is a pan-European clinical diagnostics provider with UK operations offering comprehensive pathology testing (haematology, biochemistry, microbiology, molecular) to hospitals and clinics. Comparable business model and customer base to HCA UK Laboratories.
• The Doctors Laboratory (TDL): The Doctors Laboratory is one of the largest UK private pathology providers, offering a similar multi-discipline clinical laboratory service (blood sciences, microbiology, cellular pathology, molecular diagnostics) to hospitals, clinics, and GPs. It is the most directly comparable UK private pathology competitor to HCA UK Laboratories.
• Health Services Laboratories (HSL): HSL is a major London-based pathology partnership serving NHS and private hospitals, including University College London Hospitals. Operates a similar multi-site central lab model with comparable test menu and acute hospital embedded distribution.

Emerging players

• Source BioScience: Source BioScience is a UK-based provider of clinical laboratory services and genomic/cytogenetic testing. It offers comparable specialty diagnostics (cellular pathology, molecular) and serves both private healthcare and research customers.
• Medicover Genetics / Yourgene Health UK: Yourgene Health (part of Medicover) is a UK-based molecular diagnostics company focused on reproductive health, genomics, and oncology testing. Comparable to the genomics/molecular diagnostics capabilities within HCA UK Labs, particularly for IVF and oncology testing segments.
• Randox Laboratories: Randox is a UK-based diagnostics company with growing private clinical laboratory services and an extensive in-vitro diagnostic reagent portfolio. Comparable in offering routine and specialized clinical testing, with expanding molecular diagnostics capabilities.

Broad incumbents

• Nuffield Health Pathology: Nuffield Health operates a network of private hospitals across the UK with embedded pathology and diagnostic services. Comparable to HCA UK Labs in serving private patients and consultants, though Nuffield operates a broader national hospital footprint rather than a standalone commercial lab.
• Spire Healthcare Pathology: Spire Healthcare is a major UK private hospital group that operates in-house pathology services similar to HCA UK's model. While not a standalone lab business, the embedded pathology function serves a comparable customer base (private hospital patients and consultants) within a competing hospital network.
• Sonic Healthcare UK: Sonic Healthcare is a global medical diagnostics company with UK operations through affiliated laboratories. As a much larger, publicly listed incumbent, it offers overlapping clinical pathology services with broader geographic reach and scale advantages over HCA UK Laboratories.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/HCAHealthcareUK
• LinkedInlinkedin.com/company/hcalaboratories
• Instagraminstagram.com/hcahealthcareuk

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HCAlaboratories